Bharat Immunologicals & Biologicals Corporation has informed that pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 17th October 2022, to approve the financial results of the Company for the quarter ended 30th September 2022.
The above information is a part of company’s filings submitted to BSE.